Sonorous Neurovascular announced that the FDA approved an investigational device exemption (IDE) authorizing the company to ...

AngioDynamics, Inc. announced the appointment of Eric Honroth as President, Chief Executive Officer, and a member of the company ...

Frank J. Veith, MD, Chairman of the VEITHsymposium, announced that Gustavo S. Oderich, MD, will be assuming the role of the org ...

B. Braun announced that it will wind down and close the B. Braun Interventional System Inc. (BIS) division. B. Braun stated that ...

Reva Medical, LLC announced the presentation of results from a subgroup analysis of the MOTIV BTK pivotal trial for the ...

BD (Becton, Dickinson and Company) announced 9-month results from the iliac cohort of the AGILITY investigational device ...

Johnson & Johnson MedTech announced 24-month results from the DISRUPT PAD BTK II postmarket study assessing the continued sa ...

Cordis announced that its Selution SLR Sustane percutaneous transluminal angioplasty (PTA) sirolimus drug-eluting balloon ...

Terumo Neuro announced that it has signed an agreement to acquire Arsenal Medical Inc., which is developing NeoCast, a ...

Balt announced that the first patients in North America have been enrolled in its premarket approval clinical trial, PIONEER, ...

Endologix Holdings, LLC, announced that its new corporate brand is Rhevera Medical. According to its press release, Rhevera ( ...

Inquis Medical, a developer of treatments for venous thromboembolic disease, announced the United States commercial launch of ...